Iboga vs ibogaine
Iboga root bark contains a family of alkaloids. Ibogaine is one of them. At Bwiti Life we choose whole root bark within an ancestral Missoko Bwiti process, under medical supervision. Understanding that choice means looking at both the chemistry and the care around it.
Start with the terms
The word “extract” is not enough to tell you what a preparation contains. Ask which substance is being administered and how its composition is established.
Dried root bark of Tabernanthe iboga, containing ibogaine alongside other alkaloids and plant material. Grinding it into powder does not isolate the alkaloids. Composition and potency vary between plants and batches.
An extracted mixture of alkaloids, with much of the plant material removed. The extraction method affects what is retained and in what proportions. “Total alkaloid” does not guarantee the original bark’s ratios, purity or potency.
Ibogaine prepared as a hydrochloride salt. HCl is a formulation of the same alkaloid, not an experimental analogue. A verified preparation allows its ibogaine content to be measured without the bark’s other alkaloids.
Compounds such as 18-MC and tabernanthalog have different chemical structures and pharmacology. They are not whole iboga or simply another name for purified ibogaine. See what analogue research actually shows.
Ibogaine can also be manufactured from voacangine isolated from Voacanga africana, a different African plant. That route produces ibogaine; it does not reproduce whole iboga root bark. Read about the source route and its research.
The alkaloid family
Examples reported in iboga chemistry include ibogaine, ibogamine, ibogaline, tabernanthine, coronaridine and voacangine. This is not an exhaustive inventory or a claim that every batch contains the same compounds in the same amounts.
| Compound | What research can tell us |
|---|---|
| Ibogaine | The most studied psychoactive alkaloid. Laboratory research shows activity at multiple receptors and transporters; human research includes withdrawal, craving and subjective experience. |
| Ibogamine | A related plant alkaloid with laboratory evidence of activity at α3β4 nicotinic receptors. That finding does not establish an additional clinical benefit when taken in bark. |
| Ibogaline and tabernanthine | Related alkaloids within iboga chemistry. Their individual contributions to human ceremonial experiences and treatment outcomes are much less established than ibogaine’s. |
| Coronaridine and voacangine | Related compounds studied in iboga alkaloid biosynthesis and pharmacology. Their presence does not demonstrate that the whole mixture treats more conditions. |
A 2018 chemical profiling study reported 30 alkaloids in its root-bark analysis. This is one study’s characterization of its sample, not a universal batch specification. This illustrates chemical diversity, rather than 30 established therapeutic benefits. Read the chemical profiling study.
Related primary research examines ibogaine biosynthesis and nicotinic receptor activity, alongside ibogaline and tabernanthine chemistry. Detecting a molecule, measuring an effect in cells and demonstrating a benefit in people are separate steps.
One molecule can have many actions
There is no single “addiction receptor.” Ibogaine has laboratory-demonstrated effects on NMDA receptor channels, serotonin and dopamine transporters, and nicotinic receptors. These systems participate in many functions, including learning, mood and motivation.
The body also converts ibogaine into noribogaine, an active metabolite. Noribogaine is a product of metabolism, not the same thing as taking the bark’s full mixture. Purified ibogaine can therefore have several actions even though only one alkaloid is administered. Explore how ibogaine moves through the body.
In a 2019 study of 44 participants treated with ibogaine HCl, people described emotionally significant visions, reflection on past actions and spiritual experiences. It was observational research, not proof of a cure, but it directly challenges the idea that purified ibogaine acts only on the physical layer. Read the human experience study.
Laboratory sources: NMDA receptor research and serotonin and dopamine transporter research. Receptor findings alone do not establish clinical effectiveness.
Chemistry and clinical outcomes
The whole bark preserves a broader chemical mixture. Whether its additional alkaloids improve outcomes compared with purified ibogaine is a separate question. The research cited here does not establish that advantage in a controlled human comparison.
The idea that several plant compounds work together beneficially is sometimes called an “entourage effect.” For iboga, it remains a hypothesis rather than an established clinical explanation. Additional compounds could change benefits, adverse effects or interactions. Their combined effects need investigation.
At Bwiti Life, “broader work” describes the scope of our approach: physical care, emotional reflection, relationships, meaning and spiritual life. It is a commitment to how we accompany people, not a proven pharmacological advantage over ibogaine HCl.
Addiction can involve interacting biological, psychological and social factors. Exploring underlying experiences and recurring patterns matters to our process. Neither a root nor an isolated molecule can guarantee that these factors are resolved; ongoing support and changes in daily life remain part of the work.
Our choice
The Bwiti tradition is central to why we choose whole iboga. Our practitioners apply the specific methodology transmitted through Bwiti House in Gabon, drawing on Moughenda Mikala’s Missoko Bwiti teachings. Fire talks, traditional counsel, regressive work and guided life review connect preparation, ceremony and integration. Our root bark comes from growing villages in Gabon, through fair agreements and resource sharing.
Traditional counsel around the fire creates space for intentions and questions. Preparation is part of the process, alongside medical assessment.
Practitioners accompany reflection on earlier experiences, emotions and recurring patterns. What we call regressive therapy belongs to this traditional framework. Memories and imagery are explored as personal experience, not proof of past events.
The practitioner guides the ceremony and paces administration within the medical plan. A physician provides clinical oversight. Screening and monitoring reduce some risks but do not eliminate them.
Processing days and three months of continuing care support the work after the retreat. The intention is to connect reflection with practical choices, relationships and habits, without promising permanent change.
Bwiti House describes its training as a methodology of dialogue, self-knowledge and emotional and spiritual transformation. At Bwiti Life, we bring this practitioner-led process together with dedicated medical supervision. Read about the Bwiti House methodology.
A medical clinic can also provide emotional support and integration. The distinction to ask about is the specific training, ceremonial methodology, medicine and clinical team. Explore our team and the sourced comparison with Beond.
Our practitioners’ observations
Drawing on practice since 2012, our practitioners have worked with people who reported returning to substance use after previous ibogaine treatment. Some said they felt that the underlying experiences and patterns contributing to their addiction had remained unresolved.
We have also heard from guests who describe the Bwiti Life process as entering a spiritual realm, encountering what they understand as the roots of their addiction and experiencing a profound transformation. Some report that they have not relapsed since following our protocol.
These accounts matter to our choice of whole iboga with the Bwiti House methodology. They reinforce our commitment to guided reflection, traditional counsel and continued support around the experience.
These are practitioner observations and guest reports, not a measured success rate or a controlled comparison. Follow-up durations are not specified here, and no relapse reported to date cannot establish lifelong abstinence. These accounts do not isolate the effects of the alkaloids from the methodology, medical care or integration. A return to use is a reason to seek renewed support, not a personal or spiritual failure. Read about treatment and recovery.
Research beyond the plant
Researchers alter molecular structures to investigate whether particular effects can be retained while others are reduced. An analogue’s results cannot be assumed to apply to whole iboga, and traditional experience with iboga does not establish an analogue’s safety.
A synthetic coronaridine analogue studied for effects on α3β4 nicotinic receptors and addiction-related behavior. Laboratory receptor findings describe a research direction, not proof that it resolves addiction in people. Read the receptor study.
An ibogaine-inspired compound studied in a 2021 paper for neural plasticity and addiction-related behavior in preclinical models. It lacked a mouse head-twitch response used as a proxy for hallucinogenic potential. These findings do not establish human safety or benefit. Read the original study.
These are examples of research compounds, not medicines offered at Bwiti Life. Noribogaine belongs in a different category: it is an active metabolite formed when the body processes ibogaine.
Choosing a setting
Ask for its form, origin, preparation and any available batch analysis. Whole root bark has variable potency. The source alone does not establish purity or alkaloid content.
Ask about practitioner training, clinical qualifications, monitoring, emergency response and aftercare. The setting and the substance are separate choices; a traditional process still needs medical supervision.
Iboga and ibogaine both carry serious cardiac risks. Whole bark should not be presumed safer because it is natural, and a measured HCl preparation is not risk-free. Read our safety protocol or discuss eligibility with the team.
Questions people ask
Not necessarily. The intensity depends on alkaloid content, the amount administered, individual metabolism and other factors. Neither gradual administration nor a natural source guarantees a gentle or safe experience.
Our confirmed sourcing is locally grown root bark from villages in Gabon, with fair agreements and resource sharing. Ask the team for any available batch documentation or laboratory results. This page does not claim standardized potency or independently certified purity.
No. It acts on several brain systems, and human studies describe emotional and autobiographical experiences after ibogaine HCl. Bwiti Life’s distinctive choice is the combination of whole root bark and a specific traditional process under medical supervision.
No preparation can promise that. Our guided work seeks to explore the experiences, relationships and patterns that may contribute to a person’s difficulties. Long-term recovery can also require ongoing medical care, psychological support and changes in daily circumstances.
You've carried this long enough. Start with a conversation with our medical team.
